241 related articles for article (PubMed ID: 17311922)
21. Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue.
Apostolova G; Schweizer RA; Balazs Z; Kostadinova RM; Odermatt A
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E957-64. PubMed ID: 15613680
[TBL] [Abstract][Full Text] [Related]
22. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
Iwasaki Y; Takayasu S; Nishiyama M; Tsugita M; Taguchi T; Asai M; Yoshida M; Kambayashi M; Hashimoto K
Mol Cell Endocrinol; 2008 Mar; 285(1-2):10-8. PubMed ID: 18313835
[TBL] [Abstract][Full Text] [Related]
23. The role of 11beta-hydroxysteroid dehydrogenase 1 in adipogenesis in thyroid-associated ophthalmopathy.
Tomlinson JW; Durrani OM; Bujalska IJ; Gathercole LL; Tomlins PJ; Reuser TT; Rose GE; Curnow SJ; Stewart PM; Walker EA; Rauz S
J Clin Endocrinol Metab; 2010 Jan; 95(1):398-406. PubMed ID: 19880789
[TBL] [Abstract][Full Text] [Related]
24. 11Beta-hydroxysteroid dehydrogenase 1 in adipocytes: expression is differentiation-dependent and hormonally regulated.
Napolitano A; Voice MW; Edwards CR; Seckl JR; Chapman KE
J Steroid Biochem Mol Biol; 1998 Mar; 64(5-6):251-60. PubMed ID: 9618026
[TBL] [Abstract][Full Text] [Related]
25. Genistein inhibits glucocorticoid amplification in adipose tissue by suppression of 11β-hydroxysteroid dehydrogenase type 1.
Tagawa N; Kubota S; Kobayashi Y; Kato I
Steroids; 2015 Jan; 93():77-86. PubMed ID: 25447798
[TBL] [Abstract][Full Text] [Related]
26. 11β-HSD1 modulates LPS-induced innate immune responses in adipocytes by altering expression of PTEN.
Lai W; Tian X; Xiang Q; Chu K; Wei Y; Deng J; Zhang S; Brown J; Hong G
Mol Endocrinol; 2015 Apr; 29(4):558-70. PubMed ID: 25734515
[TBL] [Abstract][Full Text] [Related]
27. 11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle.
Morgan SA; Sherlock M; Gathercole LL; Lavery GG; Lenaghan C; Bujalska IJ; Laber D; Yu A; Convey G; Mayers R; Hegyi K; Sethi JK; Stewart PM; Smith DM; Tomlinson JW
Diabetes; 2009 Nov; 58(11):2506-15. PubMed ID: 19675138
[TBL] [Abstract][Full Text] [Related]
28. A novel selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis.
Bujalska IJ; Gathercole LL; Tomlinson JW; Darimont C; Ermolieff J; Fanjul AN; Rejto PA; Stewart PM
J Endocrinol; 2008 May; 197(2):297-307. PubMed ID: 18434359
[TBL] [Abstract][Full Text] [Related]
29. Dehydroepiandrosterone exerts antiglucocorticoid action on human preadipocyte proliferation, differentiation, and glucose uptake.
McNelis JC; Manolopoulos KN; Gathercole LL; Bujalska IJ; Stewart PM; Tomlinson JW; Arlt W
Am J Physiol Endocrinol Metab; 2013 Nov; 305(9):E1134-44. PubMed ID: 24022868
[TBL] [Abstract][Full Text] [Related]
30. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
Masuzaki H; Flier JS
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456
[TBL] [Abstract][Full Text] [Related]
31. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.
Jun YJ; Park SJ; Kim TH; Lee SH; Lee KJ; Hwang SM; Lee SH
J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847
[TBL] [Abstract][Full Text] [Related]
32. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
Walker BR
Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766
[TBL] [Abstract][Full Text] [Related]
33. The environmental obesogen bisphenol A promotes adipogenesis by increasing the amount of 11β-hydroxysteroid dehydrogenase type 1 in the adipose tissue of children.
Wang J; Sun B; Hou M; Pan X; Li X
Int J Obes (Lond); 2013 Jul; 37(7):999-1005. PubMed ID: 23090578
[TBL] [Abstract][Full Text] [Related]
34. Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-beta.
Sai S; Esteves CL; Kelly V; Michailidou Z; Anderson K; Coll AP; Nakagawa Y; Ohzeki T; Seckl JR; Chapman KE
Mol Endocrinol; 2008 Sep; 22(9):2049-60. PubMed ID: 18617597
[TBL] [Abstract][Full Text] [Related]
35. 11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets.
Swali A; Walker EA; Lavery GG; Tomlinson JW; Stewart PM
Diabetologia; 2008 Nov; 51(11):2003-11. PubMed ID: 18779947
[TBL] [Abstract][Full Text] [Related]
36. Suppression of the Nrf2-dependent antioxidant response by glucocorticoids and 11β-HSD1-mediated glucocorticoid activation in hepatic cells.
Kratschmar DV; Calabrese D; Walsh J; Lister A; Birk J; Appenzeller-Herzog C; Moulin P; Goldring CE; Odermatt A
PLoS One; 2012; 7(5):e36774. PubMed ID: 22606287
[TBL] [Abstract][Full Text] [Related]
37. The rise in expression and activity of 11β-HSD1 in human mesenchymal progenitor cells induces adipogenesis through increased local cortisol synthesis.
Blaschke M; Koepp R; Streit F; Beismann J; Manthey G; Seitz MT; Kragl A; Siggelkow H
J Steroid Biochem Mol Biol; 2021 Jun; 210():105850. PubMed ID: 33639236
[TBL] [Abstract][Full Text] [Related]
38. Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11β-hydroxysteroid dehydrogenase type 1.
Lavery GG; Zielinska AE; Gathercole LL; Hughes B; Semjonous N; Guest P; Saqib K; Sherlock M; Reynolds G; Morgan SA; Tomlinson JW; Walker EA; Rabbitt EH; Stewart PM
Endocrinology; 2012 Jul; 153(7):3236-48. PubMed ID: 22555437
[TBL] [Abstract][Full Text] [Related]
39. Preadipocyte 11beta-hydroxysteroid dehydrogenase type 1 is a keto-reductase and contributes to diet-induced visceral obesity in vivo.
De Sousa Peixoto RA; Turban S; Battle JH; Chapman KE; Seckl JR; Morton NM
Endocrinology; 2008 Apr; 149(4):1861-8. PubMed ID: 18174284
[TBL] [Abstract][Full Text] [Related]
40. Benzofuran derivatives inhibit 11β-hydroxysteroid dehydrogenase type 1 activity in rat adipose tissue.
Kiyonaga D; Tagawa N; Yamaguchi Y; Wakabayashi M; Kogure T; Ueda M; Miyata O; Kobayashi Y
Biol Pharm Bull; 2012; 35(8):1275-80. PubMed ID: 22863925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]